Evidence map›Paper›PMID 38201665›Full record

ArticleCancers2023

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma.

Marco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, Akane Yamamichi, Hideho Okada

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Marco GallusDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
Darwin KwokDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
Senthilnath LakshmanachettyDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.ORCID 0000-0002-3760-2772
Akane YamamichiDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
Hideho OkadaDepartment of Neurological Surgery, University of California, San Francisco, CA 94143, USA.ORCID 0000-0003-0076-9920
University of California, San Francisco · US

Funding

Preclinical development of breakthrough immunotherapy for brain tumorsR35NS105068 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKADA, HIDEHO · 2018 to 2025
$6.0M
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppressionR01CA222965 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKADA, HIDEHO · 2018 to 2022
$1.8M
Deutsche Forschungsgemeinschaft GA 3535/1-1Gianne Ray Meadows Fund Oligodendroglioma Cure grantloglio Foundation from Dabbiere FamilyNIH/NCI R01CA222965NIH/NINDS R35NS105068NINDS NIH HHS R35 NS105068
6 · The paper itself

Abstract

It has come to our attention that the previously published manuscript contained an outdated iteration of Table 1 [...].

Identifiers

PMID38201665
PMCPMC10778241
OpenAlexW4390231676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.